Center for Scientific Review; Notice of Closed Meetings, 18658 [2017-07931]

Download as PDF asabaliauskas on DSK3SPTVN1PROD with NOTICES 18658 Federal Register / Vol. 82, No. 75 / Thursday, April 20, 2017 / Notices stakeholders. Please visit the NPRSB Web site at https://www.phe.gov/nprsb for all application submission information and instructions. If interested, please submit your application by the deadline of June 7, 2017, at 11:59 p.m. FOR FURTHER INFORMATION CONTACT: CDR Evelyn Seel, MPH, Designated Federal Official, National Preparedness and Response Science Board, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Thomas P. O’Neill Federal Building, Room Number 22H11, 200 C St. SW., Washington, DC 20024; Office: 202–205–7960, Email address: evelyn.seel@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to section 319M of the Public Health Service (PHS) Act (42 U.S.C. 247d–7f) and section 222 of the PHS Act (42 U.S.C. 217a), the Department of Health and Human Services (HHS) established the NPRSB. The Board shall provide expert advice and guidance to the Secretary on scientific, technical, and other matters of special interest to HHS regarding current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate. The Board may also provide advice and guidance to the Secretary and/or the Assistant Secretary for Preparedness and Response (ASPR) on other matters related to public health emergency preparedness and response. Description of Duties: The Board shall advise the Secretary and/or ASPR on current and future trends, challenges, and opportunities presented by advances in biological and life sciences, biotechnology, and genetic engineering with respect to threats posed by naturally occurring infectious diseases and chemical, biological, radiological, and nuclear agents. At the request of the Secretary and/or ASPR, the Board shall review and consider any information and findings received from the working groups established under 42 U.S.C. 247d–7f(b). At the request of the Secretary and/or ASPR, the Board shall provide recommendations and findings for expanded, intensified, and coordinated biodefense research and development activities. The Secretary and/or ASPR may assign additional advisory duties concerning public health emergency preparedness and response at his/her discretion. Structure: The Board shall consist of 13 voting members, including the chairperson; additionally, there may be non-voting ex officio members. Pursuant to 42 U.S.C. 247d–7f(a), the Secretary shall appoint members and the Chairperson from among the nation’s VerDate Sep<11>2014 17:27 Apr 19, 2017 Jkt 241001 preeminent scientific, public health, and medical experts, as follows: (a) Such federal officials as the Secretary determines are necessary to support the functions of the Board; (b) four individuals from the pharmaceutical, biotechnology, and device industries; (c) four academicians; and, (d) five other members as determined appropriate by the Secretary and/or ASPR, one of whom must be a practicing health care professional, one of whom must be from an organization representing health care consumers, one of whom must have pediatric subject matter expertise, and one of whom shall be a state, tribal, territorial, or local public health official. The Secretary will appoint additional members for category (d), above, from among emergency medical responders and organizations representing other appropriate stakeholders. A member of the Board described in (b), (c), or (d) in the above paragraph shall serve for a term of three years, except that the Secretary may adjust the terms of the initial Board appointees in order to provide for a staggered term of appointment of all members. The Secretary shall appoint members who are not full-time or permanent part-time federal employees as special government employees. Dated: April 14, 2017. George W. Korch Jr., Acting Assistant Secretary for Preparedness and Response. [FR Doc. 2017–08005 Filed 4–19–17; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel RFA–OD– PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 15–004—Tobacco Regulatory Sciences Small Grant Program for New Investigators (R03). Date: May 15, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Hotel Reston, 11810 Sunrise Valley Dr., Herndon, VA 20191. Contact Person: Malaya Chatterjee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, (301) 806– 2515, chatterm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel Risk Prevention and Health Behavior AREA Review. Date: May 15, 2017. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: John H. Newman, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD 20892, (301) 435– 0628, newmanjh@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group, Nuclear and Cytoplasmic Structure/Function and Dynamics Study Section. Date: May 18, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: David Balasundaram, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD 20892, 301–435– 1022, balasundaramd@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 14, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07931 Filed 4–19–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. E:\FR\FM\20APN1.SGM 20APN1

Agencies

[Federal Register Volume 82, Number 75 (Thursday, April 20, 2017)]
[Notices]
[Page 18658]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07931]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel RFA-OD-15-004--Tobacco Regulatory Sciences Small Grant Program 
for New Investigators (R03).
    Date: May 15, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Sheraton Hotel Reston, 11810 Sunrise Valley Dr., Herndon, 
VA 20191.
    Contact Person: Malaya Chatterjee, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 
20892, (301) 806-2515, chatterm@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Risk Prevention and Health Behavior AREA Review.
    Date: May 15, 2017.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: John H. Newman, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD 
20892, (301) 435-0628, newmanjh@csr.nih.gov.

    Name of Committee: Cell Biology Integrated Review Group, Nuclear 
and Cytoplasmic Structure/Function and Dynamics Study Section.
    Date: May 18, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: David Balasundaram, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD 
20892, 301-435-1022, balasundaramd@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: April 14, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07931 Filed 4-19-17; 8:45 am]
 BILLING CODE 4140-01-P